Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder-Reference-Cited by-同舟云学术

Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder

Published:2021-04 Issue: Volume:221 Page:108614
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Angarita Gustavo A.^ORCID,Matuskey David,Pittman Brian,Costeines Jessica L.,Potenza Marc N.^ORCID,Jastreboff Ania M.,Schmidt Heath D.,Malison Robert T.

Funder

National Institutes of Health

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference49 articles.

1. Dopamine agonists for the treatment of cocaine dependence;Amato;Cochrane Database Syst. Rev.,2011

2. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis;Amori;Jama,2007

3. Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases;Angarita;Pharmacol. Biochem. Behav.,2010

4. Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial;Antonsen;BMJ Open,2018

5. Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers;Ashare;J. Psychopharmacol.,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target;Pharmacological Research;2024-09

2. POTENTIAL ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN SUBSTANCE USE DISORDER: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS;Drug and Alcohol Dependence;2024-09

3. The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients;Journal of Addiction Medicine;2024-08-02

4. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder;Addiction Science & Clinical Practice;2024-07-27

5. Cocaine self-administration behavior is associated with subcortical and cortical morphometry measures in individuals with cocaine use disorder;The American Journal of Drug and Alcohol Abuse;2024-03-29